T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.52B |
| 2 |
Boeing
BA
|
+$1.89B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.43B |
| 4 |
Amphenol
APH
|
+$1.1B |
| 5 |
CME Group
CME
|
+$911M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.87B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.1B |
| 3 |
UnitedHealth
UNH
|
+$1.83B |
| 4 |
Uber
UBER
|
+$1.56B |
| 5 |
Adobe
ADBE
|
+$1.29B |
Sector Composition
| 1 | Technology | 33.26% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.7% |
| 4 | Financials | 11.14% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Arch Capital
ACGL
$33.8B
| $59.3M | 0.01% |
641,973
-107,941
| -14% | -$9.97M |
|
702
Exelixis
EXEL
$10.1B
| $58.8M | 0.01% |
1,766,841
-125,006
| -7% | -$4.16M |
|
703
Mirum Pharmaceuticals
MIRM
$3.76B
| $58.8M | 0.01% |
1,422,729
+138,623
| +11% | +$5.73M |
|
704
Uranium Energy
UEC
$5.6B
| $58.6M | 0.01% |
8,757,032
-33,500
| -0.4% | -$224K |
|
705
Willis Towers Watson
WTW
$32.2B
| $58.3M | 0.01% |
186,165
-15,474
| -8% | -$4.85M |
|
706
Halozyme
HALO
$8.87B
| $58.2M | 0.01% |
1,218,326
-52,195
| -4% | -$2.5M |
|
707
D.R. Horton
DHI
$52.5B
| $58.2M | 0.01% |
416,202
+4,570
| +1% | +$639K |
|
708
Vontier
VNT
$6.29B
| $58.2M | 0.01% |
1,595,092
-102,576
| -6% | -$3.74M |
|
709
Kroger
KR
$44.3B
| $58.1M | 0.01% |
949,956
+12,577
| +1% | +$769K |
|
710
InterDigital
IDCC
$7.7B
| $58M | 0.01% |
299,326
+280,030
| +1,451% | +$54.2M |
|
711
W.P. Carey
WPC
$14.8B
| $57.7M | 0.01% |
1,058,351
+21,954
| +2% | +$1.2M |
|
712
Procept Biorobotics
PRCT
$2.09B
| $57.5M | 0.01% |
713,856
-63,574
| -8% | -$5.12M |
|
713
Cleveland-Cliffs
CLF
$5.62B
| $56.8M | 0.01% |
6,039,638
+607,236
| +11% | +$5.71M |
|
714
IQVIA
IQV
$31.3B
| $56.7M | 0.01% |
288,512
-124,498
| -30% | -$24.5M |
|
715
Nurix Therapeutics
NRIX
$684M
| $56.7M | 0.01% |
3,007,327
-61,634
| -2% | -$1.16M |
|
716
Dyne Therapeutics
DYN
$1.89B
| $56.6M | 0.01% |
2,402,452
-233,841
| -9% | -$5.51M |
|
|
EDR
717
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $56.5M | 0.01% |
1,807,051
-135,077
| -7% | -$4.23M |
|
718
Teradyne
TER
$18.7B
| $55.2M | 0.01% |
438,631
-84,772
| -16% | -$10.7M |
|
719
Ford
F
$45.5B
| $55.1M | 0.01% |
5,570,170
-1,080,892
| -16% | -$10.7M |
|
720
Steris
STE
$24B
| $54.6M | 0.01% |
265,662
-119,727
| -31% | -$24.6M |
|
721
Guidewire Software
GWRE
$21.3B
| $54.6M | 0.01% |
323,846
-251,495
| -44% | -$42.4M |
|
722
Expro
XPRO
$1.42B
| $54.6M | 0.01% |
4,376,250
+436,411
| +11% | +$5.44M |
|
723
Xylem
XYL
$33.5B
| $54.5M | 0.01% |
469,760
-140
| -0% | -$16.2K |
|
724
Badger Meter
BMI
$5.23B
| $54.4M | 0.01% |
256,217
+166,191
| +185% | +$35.3M |
|
725
Matador Resources
MTDR
$6.16B
| $54M | 0.01% |
960,443
-150,557
| -14% | -$8.47M |
|